Literature DB >> 12124993

Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia.

S Sauter1, B Miterski, S Klimpe, D Bönsch, L Schöls, A Visbeck, T Papke, H C Hopf, W Engel, T Deufel, J T Epplen, J Neesen.   

Abstract

Hereditary spastic paraplegias (HSP) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs. Autosomal dominant hereditary spastic paraplegia 4 linked to chromosome 2p (SPG4) is the most common form of autosomal dominant hereditary spastic paraplegia. It is caused by mutations in the SPG4 gene encoding spastin, a member of the AAA protein family of ATPases. In this study the spastin gene of HSP patients from 161 apparently unrelated families in Germany was analyzed. The authors identified mutations in 27 out of the 161 HSP families; 23 of these mutations have not been described before and only one mutation was found in two families. Among the detected mutations are 14 frameshift, four nonsense, and four missense mutations, one large deletion spanning several exons, as well as four mutations that affect splicing. Most of the novel mutations are located in the conserved AAA cassette-encoding region of the spastin gene. The relative frequency of spastin gene mutations in an unselected group of German HSP patients is approximately 17%. Frameshift mutations account for the majority of SPG4 mutations in this population. The proportion of splice mutations is considerably lower than reported elsewhere. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124993     DOI: 10.1002/humu.10105

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  36 in total

1.  No correlation between amount of aberrant transcript and severity of phenotype in hereditary spastic paraplegia patients with a c.1242A > G splice mutation in the SPG4 gene.

Authors:  Simone M Sauter; Nadine Dörwald; Wolfgang Engel; Jürgen Neesen
Journal:  J Neurol       Date:  2005-12-13       Impact factor: 4.849

2.  The AAA + ATPase Thorase is neuroprotective against ischemic injury.

Authors:  Jianmin Zhang; Jia Yang; Huaishan Wang; Omar Sherbini; Matthew J Keuss; George Ke Umanah; Emily Ling-Lin Pai; Zhikai Chi; Kaisa Ma Paldanius; Wei He; Hong Wang; Shaida A Andrabi; Ted M Dawson; Valina L Dawson
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-16       Impact factor: 6.200

3.  The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Authors:  Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

4.  Evaluation of loss of function as an explanation for SPG4-based hereditary spastic paraplegia.

Authors:  Joanna M Solowska; James Y Garbern; Peter W Baas
Journal:  Hum Mol Genet       Date:  2010-04-29       Impact factor: 6.150

5.  A polymorphic Alu insertion that mediates distinct disease-associated deletions.

Authors:  Amir Jahic; Anne K Erichsen; Thomas Deufel; Chantal M Tallaksen; Christian Beetz
Journal:  Eur J Hum Genet       Date:  2016-03-02       Impact factor: 4.246

6.  REEPing the benefits of an animal model of hereditary spastic paraplegia.

Authors:  Ariel Y Deutch; Peter Hedera; Roger J Colbran
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

Review 7.  Genotype-phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients.

Authors:  Maryam Erfanian Omidvar; Shahram Torkamandi; Somaye Rezaei; Behnam Alipoor; Mir Davood Omrani; Hossein Darvish; Hamid Ghaedi
Journal:  J Neurol       Date:  2019-11-19       Impact factor: 4.849

8.  ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia.

Authors:  Ashraf U Mannan; Philip Krawen; Simone M Sauter; Johann Boehm; Agnieszka Chronowska; Walter Paulus; Juergen Neesen; Wolfgang Engel
Journal:  Am J Hum Genet       Date:  2006-06-01       Impact factor: 11.025

9.  Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements.

Authors:  Mark Braschinsky; Riin Tamm; Christian Beetz; Elena Sachez-Ferrero; Elve Raukas; Siiri-Merike Lüüs; Katrin Gross-Paju; Catherine Boillot; Federico Canzian; Andres Metspalu; Sulev Haldre
Journal:  BMC Neurol       Date:  2010-03-09       Impact factor: 2.474

10.  Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia.

Authors:  Moneef Shoukier; Juergen Neesen; Simone M Sauter; Loukas Argyriou; Nadine Doerwald; D V Krishna Pantakani; Ashraf U Mannan
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.